- New Formulation of Rebif(R) Designed to Improve Injection Tolerability Merck Serono, a division of Merck KGaA, announced today that the European Commission has ...
Rebif (interferon beta-1a) is a prescription drug that treats certain types of multiple sclerosis. Rebif’s cost may depend on factors such as your dosage, whether ...
Rebif (interferon beta-1a) is a prescription drug used to treat types of multiple sclerosis. Rebif can cause side effects that range from mild to serious. Examples ...
DARMSTADT, Germany, October 18, 2017/PRNewswire/. Merck, a leading science and technology company, today announced that data for approved and investigational multiple sclerosis (MS) treatments, ...
> Strong growth from Merck KGaA's multiple sclerosis drug Rebif and cancer treatment Erbitux helped push the German drugmakers second-quarter sales past expectations as 376 million euros' worth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback